CatalystWireBeta

Response to Statement re Possible Offer

In brief · summary, not quotable

Montagu has made a statement regarding a possible offer for AMS; the Board has not received a proposal.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your AMS notes

The Board of AMS notes the announcement made earlier today by Montagu regarding a possible offer for AMS. The Board of AMS is not in receipt of a proposal from Montagu. There can be no certainty that a firm offer will be made for AMS, nor as to the terms on which a firm offer might be made.

In accordance with Rule 2.6(a) of the Code, Montagu is required, by no later than 5.00 p.m. (London time) on 24 April 2025, being 28 days after today's date, to either announce a firm intention to make an offer for AMS in accordance with Rule 2.7 of the Code or announce that it does not intend to make an offer, in which case the announcement will be treated as a statement to which Rule 2.8 of the Code applies. This deadline can be extended with the consent of the Takeover Panel in accordance with Rule 2.6(c) of the Code.

A further announcement will be made as and when appropriate.

Advanced Medical Solutions Group plc+44 (0) 1606 545508
Evercore Partners International LLP (Financial Adviser)+44 (0) 207 653 6000
Simon Elliott Julian Oakley Torera Oyewo Harrison George
Investec Bank PLC (Financial Adviser, NOMAD and Corporate Broker)+44 (0) 207 597 5970
Gary Clarence David Anderson
ICR Consilium (PR Adviser)
Mary-Jane Elliott Lucy Featherstone+44 (0) 20 3709 5700 AMS@icrhealthcare.com

Person responsible

Rule 2.9 disclosure

Rule 26.1

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note